ABUS - Arbutus Biopharma Corp
3.29
-0.030 -0.912%
Share volume: 1,099,288
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$3.32
-0.03
-0.01%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-02-2024 | 08-03-2023 | 11-07-2023 | 11-06-2024 | 05-02-2024 | 08-08-2024 | 11-06-2024 | 03-27-2025 | |
| Total revenue | 6.687 M | 4.651 M | 4.658 M | 2.145 M | 1.532 M | 1.726 M | 1.339 M | 1.574 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 6.687 M | 4.651 M | 4.658 M | 2.145 M | 1.532 M | 1.726 M | 1.339 M | 1.574 M | |
| -30.45% | 0.15% | -53.95% | -28.58% | 12.66% | -22.42% | 17.55% | |||
| Operating expenses | 23.827 M | 23.672 M | 26.011 M | 22.665 M | 20.715 M | 23.098 M | 18.810 M | 13.522 M | |
| Selling general and admin | 5.552 M | 5.980 M | 5.842 M | 5.101 M | 5.312 M | 7.547 M | 4.537 M | 4.712 M | |
| Research and development | 18.275 M | 17.692 M | 20.169 M | 17.564 M | 15.403 M | 15.551 M | 14.273 M | 8.810 M | |
| Total expenses | 24.100 M | 23.672 M | 26.216 M | 22.892 M | 20.895 M | 23.309 M | 22.779 M | 15.507 M | |
| -1.78% | 10.75% | -12.68% | -8.72% | 11.55% | -2.27% | -31.92% | |||
| Operating income | -17.413 M | -18.385 M | -21.558 M | -20.747 M | -19.363 M | -21.583 M | -21.440 M | -13.933 M | |
| Ebit | -17.409 M | -17.748 M | -21.552 M | -20.733 M | -19.376 M | -21.591 M | -21.435 M | -13.966 M | |
| Pretax income | -16.339 M | -17.094 M | -20.104 M | -19.312 M | -17.875 M | -19.796 M | -19.717 M | -12.532 M | |
| 4.62% | 17.61% | -3.94% | -7.44% | 10.75% | -0.40% | -36.44% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -16.339 M | -17.094 M | -20.104 M | -19.312 M | -17.875 M | -19.796 M | -19.717 M | -12.532 M | |
| -4.62% | -17.61% | 3.94% | 7.44% | -10.75% | 0.40% | 36.44% |
